Augusta University - Georgia Cancer Center ( Site 0066) — Augusta, Georgia

Augusta University - Georgia Cancer Center ( Site 0066) is a clinical research site located in Augusta, Georgia, United States 30912.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Augusta University - Georgia Cancer Center ( Site 0066) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Augusta University - Georgia Cancer Center ( Site 0066)?

Augusta University - Georgia Cancer Center ( Site 0066) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Augusta University - Georgia Cancer Center ( Site 0066) conducted?

Augusta University - Georgia Cancer Center ( Site 0066) has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Augusta University - Georgia Cancer Center ( Site 0066) accredited by Crixeo Health?

Augusta University - Georgia Cancer Center ( Site 0066) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Augusta University - Georgia Cancer Center ( Site 0066)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.